12/02/2016 03:26:11 Cookie Policy +44 (0) 207 0700 961 Free Membership Login

You’ve just added your first Follow! This is a brand new feature that will be at the core of several new tools and personalized information feeds that are coming soon.

You can see your current Follow list as a Monitor list here.

Please continue to add stocks to your Follow list so that when the new tools and feeds roll out, you’ll immediately get to make use of them! We will alert early adopters of the Follow list to these new features first.

Physiomics Share Price (PYC)

Share Name Share Symbol Market Type Share ISIN Share Description
Physiomics Plc LSE:PYC London Ordinary Share GB00B04QT956 ORD 0.004P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 0.035p 0.03p 0.04p 0.0375p 0.035p 0.035p 16,104,547 14:14:40
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m) RN NRN
Health Care Equipment & Services 0.2 -0.4 -0.0 - 1.22

Physiomics (PYC) Latest News

More Physiomics News
Physiomics Takeover Rumours

Physiomics (PYC) Share Charts

1 Year Physiomics Chart

1 Year Physiomics Chart

1 Month Physiomics Chart

1 Month Physiomics Chart

Intraday Physiomics Chart

Intraday Physiomics Chart

Physiomics (PYC) Discussions and Chat

Physiomics Forums and Chat

Date Time Title Posts
08/2/201610:26PHYSIOMICS plc Virtual Tumor platform2,529
30/4/201415:39One for Haystack to deramp !1
20/12/201310:09Physiomics with Charts & News13,595
04/12/201319:04PHYSIOMICS WHAT A JOKE 00.15p GET OUT13

Add a New Thread

Physiomics (PYC) Top Chat Posts

bobdown2: as i would like pyc as a long term investment obviously i would like to see another clinical contract! an immunology contract would be the icing on the cake. toxicology take up would be the candles! a share price rise on the back of rising revenues is the goldilocks scenario! costs are rising as the company expands and revenue would take out any funding issues and hopefully show that pyc is headed for profitability. as stated in a recenr rns! yep.. contract news would drive pyc.s share price to sustainable higher levels. now the swap shares are gone lets enjoy what should be a pleasant rising share price. i am looking forward to next week..
redtelephonegreen2: The potential upside of PYC share price is unbelievably huge.Should their technology be worthy this could be a 30,40,50 bagger.To have 3 major pharma companies taking up their digital models in the last few months indicates that there is a lot of promise here.Of course its a high risk share but thats when returns are potentially the highest.By the time their technology is proven to be of imense values to the pharma/bio industies thean those not already on board would have missed the opportunity and the share price would be at 30+ times the value today.i think its a great time to buy when we already know that newsflow is not far away and there seems to be low interest.Im in for long term. Of course you have the risk of losing all but worth a shot if you are a calculated speculator.But I personally think they have a slow cashburn and are a regular benifactor from charity.
pwhite73: There may well be contract news to be announced very shortly. The problem with this company is that it attaches diluted equity issues to any contracts or support in the share price as a right of passage. Good news + buying in the stock = diluted placings. Until that equation is cancelled the share price will go nowhere. The company as a matter of principle does not allow retail shareholders to profit from any strength in the share price. History has shown this and it will repeat itself time and time again. If the company receives a takeover approach then that is the only time the cycle can be broken.
pwhite73: Nobody is doubting the technology but no one knows why the share price is still in the gutter. Only last week the US FDA refused to grant AstraZeneca approval for their lead diabetes compounds. Advising more clinical trials were still required. Perhaps this is the time for PYC but deceitful market operators are still at work here and forever will be. Always at the expense of retail shareholders. Is this new positive tide for real and can it drown them all. That is the question?.
bobdown2: hi.. i also did not like the lack of news!especialy after results that stated pyc had never received so much interest. i bought loads in the second fund raise as this is normally the bottom and a good buying point...fully funded etc.. in dismay i watched as the second fund raise was as bad as the first. it looked like another swap!!!!!!!i had intended to take my holding to the 3% mark and get a picture of the rns put up in my hallway...cool or what. but..without any new revenue, i could envisage another good rns followed by yet another fund raise! one of the reasons the share price has been weak over the the last few weeks has been me selling my 2.3%. i now have 1 million left. i noticed someone bought 8 million shares today and i wish him/her all the best. i hope he knows more about the company than i do. the lack of progress and revenue was a risk i was not prepared to take...bob
bobdown2: thanks moreforus...val is now a spike which could if selling starts drop back courtesy of the mms. any rise in pyc if accompanied by a revenue rns will have its share price underpinned! if we start to see these revenue streams then pyc has the ability to go higher than val! patience required. still adding but in drips and draps now! i have pyc indigestion....
bobdown2: poised nicely! i do not know if the latest rns and the poster news is enough to drive the share price upwards....but it has certainly ruffled the feathers of the idiots on here. they cannot post fast enough! it is strange that they believe that by interupting the thread of a buletine board that they can effect a companies share price. today is normaly a good trading volume day for pyc so it will be interesting to see an increase....
pwhite73: Yes but the key thing is it a contract in the Merck one or just another fee-for- service basis. Given the hive of activity in the pharma/health sector I still thing there are corporate moves going on irrespective of any contract deals. The fact that Merck mentioned the use of their technology in a drug development program is a major plus that has yet to be reflected in the share price.
bobdown2: pyc is a slow burn share....best of luck with rem and oct. i am hoping that pyc is like a duck where all the action is taking place under the water where you cannot see it. but if there is no additional revenue in the short term we will face more fund raising inspite of the arrival of all the so called game changing products and contract. a positive rns could take up to 6 months to arrive and the share price could double. its all about product uptake now..
bobdown2: probably the worst case scenario with an illiquid share is a swap arrangement! the effect on pyc.s share price has been horendous. that it still has a while to sort is very annoying. however the share price now is at a massive discount to the product validations, contract and fee for service buisness recieved. a typical aim share gets hammered due to the poor liquidity and if the buisness is good a sudden spike takes place...i am still buying..a seat on the board would be nice!

Physiomics (PYC) Latest Trade

Physiomics Most Recent Trade

Trade Type Trade Size Trade Price Trade Date Trade Time Currency
O 200,000 0.03 11 Feb 2016 16:11:31 GBX
Physiomics share price data is direct from the London Stock Exchange

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V: D:20160212 03:26:11